James Harris is professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine in Baltimore, where he is founding director of the Developmental Neuropsychiatry Clinic. He is also a professor at Johns Hopkins Bloomberg School of Public Health. He served on the American Psychiatric Association committee that wrote the new definition of autism spectrum disorder for the DSM-5.
James Harris
Professor of psychiatry and behavioral sciences
Johns Hopkins University School of Medicine
From this contributor
Correcting the record: Leo Kanner and the broad autism phenotype
The specter of the ‘refrigerator mother’ theory continues to haunt the history of autism. New information puts Kanner’s observations of parents into context.
Correcting the record: Leo Kanner and the broad autism phenotype
By
James Harris, Joseph Piven
26 April 2016 | 10 min read
Explore more from The Transmitter
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
By
Holly Barker
29 January 2026 | 4 min read
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
By
Paul Middlebrooks
28 January 2026 | 1 min read
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
By
Angie Voyles Askham
27 January 2026 | 7 min read